- World rank, 2022–2025
- #24,628 of 28,054 · #37,604 all time
- Rank in India
- #1,636 of 1,840
- Research works
- 244 ▲ 67% vs 2013–17
- Citations
- 2.7k 11.1 per fractional work
- Top-10% rate
- 6.5% record average 16.5%
- Open access
- 42% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 7.0×
- Immunology and Microbiology 4.8×
- Chemistry 4.3×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Medicine 2.0×
- Decision Sciences 1.7×
- Agricultural and Biological Sciences 1.2×
- Materials Science 1.2×
- Nursing 0.9×
- Mathematics 0.9×
- Arts and Humanities 0.8×
- Chemical Engineering 0.8×
- Health Professions 0.6×
- Environmental Science 0.5×
- Engineering 0.5×
- Business, Management and Accounting 0.4×
- Energy 0.4×
- Dentistry 0.4×
- Computer Science 0.4×
- Social Sciences 0.3×
- Psychology 0.2×
- Neuroscience 0.1×
- Earth and Planetary Sciences 0.1×
- Economics, Econometrics and Finance 0.0×
Which keywords describe research at Lupin Pharmaceuticals (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Myocardial Infarction, Anxiety, Treatment, Meta-Analysis, Heart Failure and Diagnosis.
- Rheological Properties
- Policy
- Hepcidin
- Prognostic Factors
- Transcriptional Regulation
- B-Type Natriuretic Peptide
- Heterocyclic Compounds
- Anticancer Agents
- Iron Deficiency
- Bioanalytical Methods
- Monoclonal Antibodies
- Immunogenicity
- Biopharmaceuticals
- Heart Failure
- Chemotherapy
- Meta-Analysis
- Depression
- Diagnosis
- Treatment
- Epidemiology
- Inflammation
- Cancer
- Cardiovascular Disease
- Anxiety
- Myocardial Infarction
- Cardiac Rehabilitation
- Coronary Heart Disease
- Nanoparticles
- Cancer Therapy
- Medicinal Chemistry
- Anemia
- Biosimilars
- Metabolism
- Guidelines
- Anti-inflammatory
- Hospital Readmission
- Cell Proliferation
- Arginine Methylation
- Iron Regulation
- Protein Arginine Methyltransferases
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation4▲ 3.5×17 topics
- Epidemiology4▲ 1.73×15 topics
- Cancer4▲ 4.6×10 topics
- Treatment3▲ 4.2×8 topics
- Cardiovascular Disease3▲ 4.1×10 topics
- Diagnosis3▲ 4.8×4 topics
- Anxiety2▲ 8.6×2 topics
- Depression2▲ 4.6×3 topics
- Myocardial Infarction2▲ 17×4 topics
- Meta-Analysis2▲ 6.6×3 topics
- Cardiac Rehabilitation2▲ 89×1 topic
- Chemotherapy2▲ 5.2×11 topics
- Coronary Heart Disease2▲ 89×1 topic
- Heart Failure2▲ 8.3×6 topics
- Nanoparticles2▲ 2.7×9 topics
- Biopharmaceuticals2▲ 62×3 topics
- Cancer Therapy2▲ 5.8×10 topics
- Immunogenicity2▲ 74×3 topics
- Medicinal Chemistry2▲ 12×4 topics
- Monoclonal Antibodies2▲ 34×2 topics
- Anemia2▲ 30×3 topics
- Bioanalytical Methods2▲ 131×1 topic
- Biosimilars2▲ 131×1 topic
- Iron Deficiency2▲ 50×2 topics
- Metabolism2▲ 5.1×4 topics
- Anticancer Agents2▲ 16×2 topics
- Guidelines2▲ 5.1×2 topics
- Heterocyclic Compounds2▲ 28×2 topics
- Anti-inflammatory1▲ 8.5×6 topics
- B-Type Natriuretic Peptide1▲ 47×1 topic
- Hospital Readmission1▲ 47×1 topic
- Transcriptional Regulation1▲ 14×3 topics
- Cell Proliferation1▲ 25×2 topics
- Prognostic Factors1▲ 5.0×3 topics
- Arginine Methylation1▲ 70×1 topic
- Hepcidin1▲ 49×1 topic
- Iron Regulation1▲ 49×1 topic
- Policy1▲ 8.7×2 topics
- Protein Arginine Methyltransferases1▲ 70×1 topic
- Rheological Properties1▲ 10×2 topics
Which research topics does Lupin Pharmaceuticals (India) publish most on?
By volume in 2022–2025: Cardiac Health and Mental Health, Biosimilars and Bioanalytical Methods, Heart Failure Treatment and Management and Cancer-related gene regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cardiac Health and Mental Health Cardiology and Cardiovascular Medicine 2 works
- 2 Biosimilars and Bioanalytical Methods Immunology 2 works
- 3 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
- 4 Cancer-related gene regulation Molecular Biology 1 works
- 5 Iron Metabolism and Disorders Hematology 1 works
- 6 Synthesis and biological activity Organic Chemistry 1 works
- 7 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
- 8 Biomedical and Engineering Education Biomedical Engineering 1 works
- 9 Agricultural Economics and Practices General Agricultural and Biological Sciences 1 works
- 10 Interdisciplinary Research and Collaboration Information Systems and Management 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lupin Pharmaceuticals (India)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.